Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 4, 2006, Pages

  Dziarmaga, Alison ^a   Hueber, Pierre Alain ^b   Iglesias, Diana ^a   Hache, Nancy ^a   Jeffs, Aaron ^c   Gendron, Nathalie ^d   MacKenzie, Alex ^d   Eccles, Michael ^c   Goodyer, Paul ^a,b  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Kidney development; Naip (Birc1); Renal hypoplasia

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 3; CASPASE 7; NEURONAL APOPTOSIS INHIBITORY PROTEIN; TRANSCRIPTION FACTOR PAX2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FETUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; TRANSCRIPTION INITIATION;

EID: 33749400597     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00004.2006     Document Type: Article

References (53)

1. Akutsu T, Nishio H, Sumino K, Takeshima Y, Tsuneishi S, Wada H, Takada S, Matsuo M, and Nakamura H. Molecular genetics of spinal muscular atrophy: contribution of the NAIP gene to clinical severity. Kobe J Med Sci 48: 25-31, 2002.
2. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, and Sereni F. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111: e382-e387, 2003.
3. Biosystems A. User Bulletin #2. ABI Prism 7700 Sequence Detection System, 2001, p. 36.
4. Bouchard M, Souabni A, Mandler M, Neubuser A, and Busslinger M. Nephric lineage specification by Pax2 and Pax8. Genes Dev 16: 2958-2970, 2002.
5. Brophy PD, Ostrom L, Lang KM, and Dressler GR. Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development 128: 4747-4756, 2001.
6. Cai Q, Dmitrieva NI, Ferraris JD, Brooks HL, van Balkom BW, and Burg M. Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance. Proc Natl Acad Sci USA 102: 503-508, 2005.
7. Clark AT and Bertram JF. Molecular regulation of nephron endowment. Am J Physiol Renal Physiol 276: F485-F497, 1999.
8. Clark P, Dziarmaga A, Eccles M, and Goodyer P. Rescue of defective branching nephrogenesis in renal-coloboma syndrome by the caspase inhibitor, Z-VAD-fmk. J Am Soc Nephrol 15: 299-305, 2004.
9. Cullen-McEwen LA, Kett MM, Dowling J, Anderson WP, and Bertram JF. Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension 41: 335-340, 2003.
10. Dressler GR, Deutsch U, Chowdhury K, Nornes HO, and Gruss P. Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 109: 787-795, 1990.
11. Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, and Westphal H. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362: 65-67, 1993.
12. Dziarmaga A, Clark P, Stayner C, Julien JP, Torban E, Goodyer P, and Eccles M. Ureteric bud apoptosis and renal hypoplasia in transgenic PAX2-Bax fetal mice mimics the renal-coloboma syndrome. J Am Soc Nephrol 14: 2767-2774, 2003.
13. Endrizzi MG, Hadinoto V, Growney JD, Miller W, and Dietrich WF. Genomic sequence analysis of the mouse Naip gene array. Genome Res 10: 1095-1102, 2000.
14. Favor J, Sandulache R, Neuhauser-Klaus A, Pretsch W, Chatterjee B, Senft E, Wurst W, Blanquet V, Grimes P, Sporle R, and Schughart K. The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. Proc Natl Acad Sci USA 93: 13870-13875, 1996.
15. Flock G and Drucker DJ. Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestine. Mol Endocrinol 16: 2349-2359, 2002.
16. Gotz R, Karch C, Digby MR, Troppmair J, Rapp UR, and Sendtner M. The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. Hum Mol Genet 9: 2479-2489, 2000.
17. Grieshammer U, Cebrian C, Ilagan R, Meyers E, Herzlinger D, and Martin GR. FGF8 is required for cell survival at distinct stages of nephrogenesis and for regulation of gene expression in nascent nephrons. Development 132: 3847-3857, 2005.
18. Holcik M, Thompson CS, Yaraghi Z, Lefebvre CA, MacKenzie AE, and Korneluk RG. The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)-deleted mice display increased vulnerability to kainic acid-induced injury. Proc Natl Acad Sci USA 97: 2286-2290, 2000.
19. Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, and Bertram JF. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl 83: S31-S37, 2003.
20. Hutchison JS, Derrane RE, Johnston DL, Gendron N, Barnes D, Fliss H, King WJ, Rasquinha I, MacManus J, Robertson GS, and MacKenzie AE. Neuronal apoptosis inhibitory protein expression after traumatic brain injury in the mouse. J Neurotrauma 18: 1333-1347, 2001.
21. Ingram-Crooks J, Holcik M, Drmanic S, and MacKenzie AE. Distinct expression of neuronal apoptosis inhibitory protein (NAIP) during murine development. Neuroreport 13: 397-402, 2002.
22. Keller G, Zimmer G, Mall G, Ritz E, and Amann K. Nephron number in patients with primary hypertension. N Engl J Med 348: 101-108, 2003.
23. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, LePaslier D, Frézal J, Cohen D, Weissenback J, Munnich A, and Melki J. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80: 155-165, 1995.
24. Liston P, Fong WG, and Korneluk RG. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22: 8568-8580, 2003.
25. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, and Korneluk RG. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349-353, 1996.
26. ΔΔC(T) method. Methods 25: 402-408, 2001.
27. Maier JK, Lahoua Z, Gendron NH, Fetni R, Johnston A, Davoodi J, Rasper D, Roy S, Slack RS, Nicholson DW, and MacKenzie AE. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 22: 2035-2043, 2002.
28. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, and Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76-79, 1996.
29. Muratovska A, Zhou C, He S, Goodyer P, and Eccles MR. Paired-box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22: 7989-7997, 2003.
30. Nemoto T, Kitagawa M, Hasegawa M, Ikeda S, Akashi T, Takizawa T, Hirokawa K, and Koike M. Expression of IAP family proteins in esophageal cancer. Exp Mol Pathol 76: 253-259, 2004.
31. Nornes HO, Dressler GR, Knapik EW, Deutsch U, and Gruss P. Spatially and temporally restricted expression of Pax2 during murine neurogenesis. Development 109: 797-809, 1990.
32. Nyengaard JR and Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 232: 194-201, 1992.
33. Ostrom L, Tang MJ, Gruss P, and Dressler GR. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease. Dev Biol 219: 250-258, 2000.
34. Perrelet D, Ferri A, MacKenzie AE, Smith GM, Korneluk RG, Liston P, Sagot Y, Terrado J, Monnier D, and Kato AC. IAP family proteins delay motoneuron cell death in vivo. Eur J Neurosci 12: 2059-2067, 2000.
35. Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, and Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 73-76, 1996.
36. Porteous S, Torban E, Cho NP, Cunliffe H, Chua L, McNoe L, Ward T, Souza C, Gus P, Giugliani R, Sato T, Yun K, Favor J, Sicotte M, Goodyer P, and Eccles M. Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice. Hum Mol Genet 9: 1-11, 2000.
37. Ramchandran R, Bengra C, Whitney B, Lanclos K, and Tuan D. A (GATA)(7) motif located in the 5′ boundary area of the human beta-globin locus control region exhibits silencer activity in erythroid cells. Am J Hematol 65: 14-24, 2000.
38. Rowitch DH and McMahon AP. Pax-2 expression in the murine neural plate precedes and encompasses the expression domains of Wnt-1 and En-1. Mech Dev 52: 3-8, 1995.
39. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner-Johnston A, Lefebvre C, Kang X, Salih M, Aubrey H, Tamai K, Guan X, Ioannu P, Crawford TO, de Jong PJ, Surh L, Ikeda J-E, Korneluk RG, and Mackenzie A. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167-178, 1995.
40. Salomon R, Tellier AL, Attie-Bitach T, Amiel J, Vekemans M, Lyonnet S, Dureau P, Niaudet P, Gubler MC, and Broyer M. PAX2 mutations in oligomeganephronia. Kidney Int 59: 457-462, 2001.
41. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, and Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382: 70-73, 1996.
42. Sanyanusin P, McNoe LA, Sullivan MJ, Weaver RG, and Eccles MR. Mutation of PAX2 in two siblings with renal-coloboma syndrome. Hum Mol Genet 4: 2183-2184, 1995.
43. Sanyanusin P, Schimmenti LA, McNoe LA, Ward TA, Pierpont ME, Sullivan MJ, Dobyns WB, and Eccles MR. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 9: 358-364, 1995.
44. Sariola H and Saarma M. Novel functions and signalling pathways for GDNF. J Cell Sci 116: 3855-3862, 2003.
45. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, and Reed JC. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-1803, 2000.
46. Torban E, Eccles MR, Favor J, and Goodyer PR. PAX2 suppresses apoptosis in renal collecting duct cells. Am J Pathol 157: 833-842, 2000.
47. Torres M, Gomez-Pardo E, Dressler GR, and Gruss P. Pax-2 controls multiple steps of urogenital development. Development 121: 4057-4065, 1995.
48. Towers PR, Woolf AS, and Hardman P. Glial cell line-derived neurotrophic factor stimulates ureteric bud outgrowth and enhances survival of ureteric bud cells in vitro. Exp Nephrol 6: 337-351, 1998.
49. Winyard PJ, Risdon RA, Sams VR, Dressler GR, and Woolf AS. The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clin Invest 98: 451-459, 1996.
50. Xu DG, Crocker SJ, Doucet JP, St-Jean M, Tamai K, Hakim AM, Ikeda JE, Liston P, Thompson CS, Korneluk RG, MacKenzie A, and Robertson GS. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 3: 997-1004, 1997.
51. Xu M, Okada T, Sakai H, Miyamoto N, Yanagisawa Y, MacKenzie AE, Hadano S, and Ikeda JE. Functional human NAIP promoter transcription regulatory elements for the NAIP and PsiNAIP genes. Biochim Biophys Acta 1574: 35-50, 2002.
52. Yaraghi Z, Korneluk RG, and MacKenzie A. Cloning and characterization of the multiple murine homologues of NAIP (neuronal apoptosis inhibitory protein). Genomics 51: 107-113, 1998.
53. Ye W, Bouchard M, Stone D, Liu X, Vella F, Lee J, Nakamura H, Ang SL, Busslinger M, and Rosenthal A. Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8. Nat Neurosci 4: 1175-1181, 2001.